No Data
No Data
Revenues Working Against Teva Pharmaceutical Industries Limited's (NYSE:TEVA) Share Price Following 26% Dive
Druckenmiller's Duquesne Adds Airlines, Exits Microsoft, Broadcom, Others
Teva Pharmaceutical Industries Insider Sold Shares Worth $2,886,565, According to a Recent SEC Filing
Spotlight on Teva Pharmaceutical Indus: Analyzing the Surge in Options Activity
Axsome Therapeutics Shares Jump Almost 20%, Resolves Generic Patent Litigation With Teva Over Depression Drug
Top Midday Gainers